文献速递其他结缔组织病

弥漫性皮肤系统性硬化症中新成纤维细胞亚群的鉴定

Identification of novel fibroblast subsets in diffuse cutaneous systemic sclerosis.
PubMed 文献 · Ann Rheum Dis · 2025-12-27

本研究对健康供者和弥漫性皮肤系统性硬化症患者培养的皮肤成纤维细胞进行单细胞RNA测序,发现SSc成纤维细胞具有高度异质性,特定活化亚群中CD9和FHL1强烈上调。CD9与FHL1表达调控相关,FHL1下调伴随VGLL3基因下调,VGLL3在SSc供者皮肤中确认上调。数据提示FHL1参与细胞外基质产生调控并与VGLL3调控存在新机制联系。

要点

  • SSc成纤维细胞存在高度异质性,特定活化亚群中CD9和FHL1强烈上调。
  • CD9与FHL1表达调控相关,FHL1下调伴随VGLL3基因下调。
  • VGLL3在SSc供者皮肤中确认上调,提示FHL1参与ECM产生调控。

核心结论

  • 本研究在SSc中鉴定出以CD9和/或FHL1上调为特征的新成纤维细胞亚群。
  • 数据提示FHL1在成纤维细胞中具有功能作用并参与ECM产生调控,且与VGLL3调控存在新机制联系。

研究设计与样本

  • 对健康供者和弥漫性皮肤SSc患者培养的皮肤成纤维细胞进行单细胞RNA测序。
  • 在蛋白水平验证所选特定基因,并使用siRNA敲低实验为这些蛋白的功能作用提供证据。

主要发现

  • SSc成纤维细胞显示高度异质性,特定活化亚群中CD9和FHL1强烈上调。
  • 患者皮肤成纤维细胞亚群中也检测到FHL1和CD9过表达。
  • CD9与FHL1表达调控相关。
  • 原代皮肤成纤维细胞中FHL1下调与VGLL3基因下调相关。
  • VGLL3在SSc供者皮肤中确认上调。

临床怎么用

  • 本研究提示靶向纤维化成纤维细胞活化可能为SSc治疗探索提供新方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Systemic sclerosis (SSc) is an autoimmune-driven fibrotic disease, characterised by excessive extracellular matrix (ECM) deposition and fibroblast activation. Our study aimed to identify novel fibroblast subpopulations in SSc and determine their functional role. METHODS: We performed single-cell RNA sequencing on cultured dermal fibroblasts from healthy donors and patients with diffuse cutaneous SSc, verified selected, specific genes at the protein level and used siRNA knockdown experiments to provide evidence for a functional role of these proteins. RESULTS: SSc fibroblasts revealed high heterogeneity and in specific activated subsets strong upregulation of CD9 and four and a half LIM domain 1 (FHL1), previously described as a muscle-related protein. Overexpression of FHL1 and CD9 was also detected in fibroblast subsets in patient skin. CD9 was associated with the regulation of FHL1 expression. Downmodulation of FHL1 in primary skin fibroblasts correlated with downregulation of the vestigial-like family member 3 (VGLL3) gene, which is known to be expressed in myofibroblasts in a stiff and fibrotic environment and to upregulate collagen synthesis. Further, VGLL3 was confirmed to be upregulated in SSc donor skin. CONCLUSIONS: Our study identified novel fibroblast subsets in SSc, characterised by CD9 and/or FHL1 upregulation. The data indicate a functional role of FHL1 in fibroblasts and its involvement in the regulation of ECM production and provide a new mechanistic link to VGLL3 regulation. Our findings suggest new avenues for therapeutic exploration targeting the perpetuating fibroblast activation by the fibrotic environment.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Rosendahl AS, Bornikoel A, Zeinert I, et al. Identification of novel fibroblast subsets in diffuse cutaneous systemic sclerosis. Ann Rheum Dis. 2025. PMID: 41457004. doi:10.1016/j.ard.2025.11.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。